Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 32.60
-0.65 (-1.95%)
Mar 24, 2026, 1:30 PM CST
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 4.63 billion as of March 24, 2026. Its market cap has decreased by -10.14% in one year.
Market Cap
4.63B
Enterprise Value
6.18B
Revenue
1.58B
Ranking
n/a
PE Ratio
n/a
Stock Price
32.60
Market Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.63B, an increase of 576.63%. That is a compound annual growth rate of 9.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 4.63B | 2.62% |
| Dec 31, 2025 | 4.51B | - |
| Dec 31, 2024 | 4.51B | -27.70% |
| Dec 29, 2023 | 6.24B | 33.24% |
| Dec 30, 2022 | 4.69B | -41.43% |
| Dec 30, 2021 | 8.00B | -2.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CHO Pharma | 5.43B |
| Panion & Bf Biotech | 5.32B |
| Senhwa Biosciences | 5.10B |
| Pharmosa Biopharm | 5.05B |
| Locus Cell | 5.01B |
| OBI Pharma | 5.01B |
| UnicoCell Biomed | 4.83B |
| BioGend Therapeutics | 4.30B |